Products Antibodies Polyclonal Antibodies Anti-OBSCN Polyclonal Antibody for WB, IF/ICC, IF-P, ELISA - Q5VST9
Anti-OBSCN Polyclonal Antibody for WB, IF/ICC, IF-P, ELISA - Q5VST9

Polyclonal Antibodies

Anti-OBSCN Polyclonal Antibody for WB, IF/ICC, IF-P, ELISA - Q5VST9

Item Number : CM0021061

Price varies based on specs and customizations


Application
WB, IF/ICC, IF-P, ELISA
Cross Reactivity
Human, Mouse, Rat
Protein Weight
868kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name OBSCN Rabbit pAb
Remarks/Alias UNC89; RHABDO1; ARHGEF30; OBSCN
Species Human
GeneID (human) 84033
GeneID 84033
Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 1621-1710 of human OBSCN (NP_443075.3)
Source Rabbit
Category Polyclonal Antibodies
Application WB, IF/ICC, IF-P, ELISA
Cross Reactivity Human, Mouse, Rat
SWISS Q5VST9
Protein Weight 868kDa
Shipping Ice bag

Biological Background: Obscurin Function and Localization

  • Obscurin (gene OBSCN) is a giant scaffolding protein (~868 kDa) expressed in striated muscle, essential for myofibrillogenesis and sarcomere organization (PubMed:11448995, PubMed:16205939). Related references: PMID:11448995 PMID:16205939
  • It localizes to both M-lines and Z-lines of sarcomeres, as well as the sarcolemma and nucleus, playing roles in structural integrity and signaling.
  • Acts as a serine/threonine kinase that phosphorylates N-cadherin (CDH2) and the sodium/potassium-ATPase subunit ATP1B1 (By similarity).
  • Binds specific phosphoinositides via its PH domain, with high affinity for PtdIns(3,4)P2 and PtdIns(4,5)P2, linking membrane dynamics to cytoskeletal architecture (PubMed:28826662). Related references: PMID:28826662
  • Contains multiple immunoglobulin domains, fibronectin type III repeats, SH3 domains, and RhoGEF and MLCK-like kinase domains, indicating multifunctional scaffold and signaling capabilities.
  • Alternative splicing produces distinct isoforms, including Obscurin-RhoGEF and Obscurin-MLCK, which likely have specialized tissue-specific roles.
  • Keywords: muscle protein, kinase, lipid-binding, developmental protein, differentiation, disease variant – underscoring its importance in muscle development and disease.

Experimental Guidance and Technical Tips

  • The immunogen corresponds to a conserved region within the N-terminal portion of human OBSCN; cross-reactivity with mouse and rat suggests sequence homology in this domain.
  • For Western blotting, account for the extremely large molecular weight (~868 kDa) by using appropriate gel systems (e.g., low-percentage/gradient gels and extended transfer conditions) and a high-molecular-weight marker.
  • In immunofluorescence/immunocytochemistry, typical staining is observed at M-lines and Z-lines; co-localization with established sarcomeric markers (e.g., α-actinin) is recommended for validation.
  • ELISA may be performed using the recombinant immunogen as a control; optimization of coating and detection conditions is advised.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio provides a comprehensive portfolio of IVD-grade antibodies and ancillary reagents tailored for muscle disease biomarker development and sarcomere protein research. With validated polyclonal antibodies like this anti-OBSCN, alongside custom antibody production, bulk antigen supply, and technical consultation, CamelBio accelerates your assay development from concept to clinic. Our expertise in rare target raw-material sourcing ensures you have the critical tools needed for striated muscle and myofibrillogenesis studies.

View more faqs for this product

Product Datasheet

Anti-OBSCN Polyclonal Antibody for WB, IF/ICC, IF-P, ELISA - Q5VST9


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!